about
Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?Perils and pitfalls of long-term effects of proton pump inhibitors.Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implicationsAdverse effects of long-term proton pump inhibitor therapy.Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting SystemProton-pump inhibitor use is associated with lower urinary magnesium excretionThe use of natural health products by paediatric patients in respite care.Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors.'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional StudyOut-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control studyHypomagnesaemia associated with long-term use of proton pump inhibitorsDoes long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?A patient on long-term proton pump inhibitors develops sudden seizures and encephalopathy: an unusual presentation of hypomagnesaemia.Proton pump inhibitor associated hypomagnasaemia - a cause for concern?Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias.Potential harms of proton pump inhibitor therapy: rare adverse effects of commonly used drugsUpdate on fundoplication for the treatment of GERD.Systematic review: hypomagnesaemia induced by proton pump inhibition.Systems pharmacology modeling: an approach to improving drug safety.Hypomagnesemia in the intensive care unit: Choosing your gastrointestinal prophylaxis, a case report and review of the literature.Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review.Local protective effects of oral 45S5 bioactive glass on gastric ulcers in experimental animals.Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?Significance of serum magnesium levels in critically ill-patients.Proton pump inhibitor-induced hypomagnesemia: A new challenge.Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention.Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.The association of proton pump inhibitors and hypomagnesemia in the community setting.Proton-pump inhibitor use is associated with low serum magnesium concentrations.Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.Omeprazole suppressed plasma magnesium level and duodenal magnesium absorption in male Sprague-Dawley rats.Severe proton pump inhibitor-induced hypomagnesaemia in a mother and daughter.Uses of proton pump inhibitors and hypomagnesemia.Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor.
P2860
Q30620638-DF78A546-CBEE-4054-965F-38276B66BD58Q33409626-CAE05273-8F59-4264-8773-6DEEF0E1BA4CQ33949498-E2DAB67B-33E7-4787-9ED7-0239EC82B77EQ34167899-FDACE496-1EAA-4AAE-AEF0-42B9583BEDA1Q34320987-1616FFB9-93AB-468E-B0B4-26F3164C0DB8Q35038136-9B8ACB92-65BE-441C-89DA-4133A82D98D9Q35099144-69ADF021-AE4D-4896-9162-88CC28AC9602Q35614268-7FECF56F-6447-4F4F-B428-87599F5CED1DQ35777866-95181120-3863-4251-99A0-30F096BFA5ADQ35855528-6C9B4400-5718-493F-925C-F8080FCB7FDDQ35899886-5D4083E5-F9AD-4E9E-AD71-B9AE7E85E8D6Q35923371-DDF39152-E148-467D-A2D5-04F5253795AFQ35943358-4F2FCF1A-83A1-4E2F-84A0-082B5497A7C4Q36424604-1DA4E7F2-9862-4850-918D-EC1CA97E2D2EQ36706785-7348B48C-E82D-4DD7-89F5-F3832C85CC74Q36980605-82E0B768-A44B-4FB3-AD23-B7D09E0C433FQ36993852-9AF6FD15-FEC3-424E-9697-F9D9C6ED1964Q37991218-9CDD4829-BD5F-4BB5-9C4A-2019FF12054EQ38023882-D0B21601-C823-4A72-A264-B2FF5B8C6E96Q38153621-3E02D8A6-2F52-4A52-BBF5-39AAE4E9652AQ38237373-2F50223C-AB18-486E-888B-5C791C828F69Q39080559-D869534A-0DA9-4B16-8C3B-3A29CBBE6E52Q39208750-BEC88A0B-CD61-41A3-816F-3898D8DF0317Q41267128-2C08921E-D07E-4EA0-8B87-7733B879510AQ41970394-9E68468B-E9CF-463C-A956-EFA335341230Q42969618-5A8C9F9B-1832-498D-9FE4-938FA7B26CF2Q43249963-E8288CA7-CD9E-4A45-BDB2-DC37D848A0CFQ43457054-3B7D8BD7-EBDC-432A-91C6-C68BBB8588F9Q44104361-3E3A71BB-9B80-448A-915F-E7D950E635E4Q44522863-20904CBF-EEA7-4776-BE74-C5814B42F123Q49070652-45F3C4DA-7199-4091-8B30-8CA5E8FCF8FEQ51315381-0A0F5C27-5C3B-403A-9AE6-7E46C89BCB56Q53463931-54179946-C88E-4C3F-B0E5-0F47931B2E1CQ53663004-33B00386-507D-418B-B5F3-47CFD30B9CF3Q54456529-7A7766F3-CCFB-4642-B8A0-5F1B7C685CAB
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proton pump inhibitors and severe hypomagnesaemia.
@en
Proton pump inhibitors and severe hypomagnesaemia.
@nl
type
label
Proton pump inhibitors and severe hypomagnesaemia.
@en
Proton pump inhibitors and severe hypomagnesaemia.
@nl
prefLabel
Proton pump inhibitors and severe hypomagnesaemia.
@en
Proton pump inhibitors and severe hypomagnesaemia.
@nl
P1476
Proton pump inhibitors and severe hypomagnesaemia
@en
P2093
Jonathan Mackay
P304
P356
10.1097/MOG.0B013E32833FF5D6
P577
2011-03-01T00:00:00Z